Bo Liu

21PUBLICATIONS
11CO-AUTHORS
Molecular targetsPharmacogenomicsBiologically active moleculesCell development, proliferation and deathLegal ethics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 22, 2026
Drugging ERK1/2 in Cancer: A Glimpse of Small-Molecule Inhibitors.

|May 31, 2026
Discovery of a novel dual-target modulator of ULK1 and ERK1/2 that suppresses triple-negative breast cancer progression and metastasis via the Exo70/Cav-1/MMPs axis.

|May 11, 2026
Integrated clinical and computational data-based repurposing of econazole as a novel autophagic activator in ULK1-related Parkinson disease.

|May 21, 2024
Rethinking therapeutic strategies of dual-target drugs: An update on pharmacological small-molecule compounds in cancer.

Yiren Yang, Yi Mou, Lin-Xi Wan

|Jan 30, 2023
Targeting regulated cell death with plant natural compounds for cancer therapy: A revisited review of apoptosis, autophagy-dependent cell death, and necroptosis.

Yuanyuan Yang, Yanmei Chen, Jun Hao Wu

|Jan 30, 2023
Application of Novel Degraders Employing Autophagy for Expediting Medicinal Research.

Xiang Li, Qian Liu, Xin Xie

Pageof 4

Frequent Collaborators

8 joint publications

Liang Ouyang

5 joint publications

Gu He

2 joint publications

Guan Wang

2 joint publications

Cheng-Ming Chiang